Septra and Copd - a phase IV clinical study of FDA data

Summary:

Copd is reported as a side effect among people who take Septra (sulfamethoxazole; trimethoprim), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Lasix, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Copd when taking Septra. It is created by eHealthMe based on reports of 9,928 people who have side effects when taking Septra from the FDA, and is updated regularly.

What is Septra?

Septra has active ingredients of sulfamethoxazole; trimethoprim. It is often used in urinary tract infection. eHealthMe is studying from 10,280 Septra users. Check the latest studies of Septra.

What is Copd?

Copd (chronic obstructive pulmonary disease) is found to be associated with 1,879 drugs and 2,195 conditions by eHealthMe. Check the latest studies of Copd.

On Jun, 16, 2026

9,928 people reported to have side effects when taking Septra.
Among them, 86 people (0.87%) have Copd.

Among these 86 people:

How long have people been on Septra when they have Copd? *

What is the gender of people who have Copd when taking Septra? *

female: 43.9 %
male: 56.1 %

What is the age of people who have Copd when taking Septra? *

What are other drugs people take besides Septra? *

What are other side effects people have besides Copd? *

Dyspnea (difficult or laboured breathing): 66 people, 76.74%
Chest Pain: 58 people, 67.44%
Fatigue (feeling of tiredness): 41 people, 47.67%
Gait Disturbance: 36 people, 41.86%
Cough: 36 people, 41.86%
Depression: 34 people, 39.53%
Joint Pain: 33 people, 38.37%
Dizziness: 32 people, 37.21%
High Blood Pressure: 32 people, 37.21%
Anaemia (lack of blood): 32 people, 37.21%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 32 people, 37.21%
High Blood Pressure: 25 people, 29.07%
Fluid Retention (an abnormal accumulation of fluid in the blood): 24 people, 27.91%
Diarrhea: 23 people, 26.74%
Mood Swings (an extreme or rapid change in mood): 23 people, 26.74%
Seborrhoeic Dermatitis (a common, inflammatory skin condition that causes flaky, white to yellowish scales to form on oily areas such as the scalp): 23 people, 26.74%
Joint Pain: 23 people, 26.74%
High Blood Cholesterol: 23 people, 26.74%
Asthma: 20 people, 23.26%
Seasonal Allergy (allergic condition due to certain season): 18 people, 20.93%

* Approximation only. Some reports may have incomplete information.

Do you take Septra and have Copd?

- Check whether Copd is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Septra:

Septra (10,280 reports)

Copd treatments and more:

Copd (198,253 reports)

How severe was Copd and when was it recovered:

Copd in Septra

Expand to all the drugs that have ingredients of sulfamethoxazole; trimethoprim:

Copd and drugs with ingredients of sulfamethoxazole; trimethoprim (699 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Septra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Copd:

Copd (1,879 drugs)

Browse all the conditions that are associated with Copd:

Copd (2,195 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on sulfamethoxazole; trimethoprim (the active ingredients of Septra) and Septra (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.